Wegovy on Sale: Why Discount Offers Are a Red Flag, Not a Deal

Why is Wegovy never legitimately on sale or discounted?

Wegovy is classified as a Prescription-Only Medicine under the Human Medicines Regulations 2012. That classification does more than require a prescription, it also prohibits any form of promotional advertising directed at the public. Discounts, voucher codes, flash sales and "limited-time offers" attached to a POM are not just commercially risky; they are contrary to the regulatory framework that governs how these medicines reach patients.

A question our prescribers hear most weeks is some version of: "I found Wegovy cheaper on this website, is it real?" The honest answer is that if a seller is advertising semaglutide with a discount code, a promotional banner, or a price that sits well below anything a licensed pharmacy could sustain, the medicine's provenance is the thing to question first. The MHRA has repeatedly warned the public about counterfeit and illegally supplied weight-loss pens, fake products have reached patients via social-media sellers and unregistered websites, and some have caused serious harm.

None of this means Wegovy costs the same everywhere. Legitimate price differences do exist. What they reflect is variation in what the price covers: some providers charge separately for the consultation, the prescription and delivery. Others, like a service with a single transparent fee, bundle those costs together. That is a legitimate comparison to make. If you want to understand the broader picture of how Wegovy sales work across the UK market, it is worth reading before drawing any conclusions about pricing. An offer structured around a medicine discount is not.

What do legitimate Wegovy prices in the UK actually look like?

Wegovy is a branded, patent-protected medicine with a fixed supply chain. Providers buy it from Novo Nordisk's authorised UK distributor and cannot buy it "cheaper" from some alternative source without leaving the licensed supply chain entirely, which no registered pharmacy does.

Typical private Wegovy pricing in the UK reflects the cost of the medicine itself, alongside clinical assessment, prescription and aftercare. If you are researching costs, the realistic Wegovy pricing landscape in the UK covers what the market looks like by dose and what the numbers mean in practice. One point worth noting: the starting dose (0.25 mg) is a tolerability phase, the medicine ramps up gradually to 2.4 mg, or now up to the newer 7.2 mg maintenance option approved by the MHRA in April 2026, so the monthly cost over a course of treatment shifts as doses increase.

For context, Eli Lilly's September 2025 price increase for Mounjaro drew considerable attention; tirzepatide pricing now runs from roughly £149 to £375 a month depending on dose and provider. Wegovy sits in a broadly comparable private market, and anyone tracking how Wegovy sales have developed through 2025 will find that pricing and availability have shifted notably as supply has stabilised. The specific current price at any given provider is shown on their treatment page, not in body text, that is how regulated pharmacies handle POM pricing.

What should I look for in a safe, legitimate Wegovy provider?

Start with the GPhC pharmacy register. Every online pharmacy dispensing prescription medicines in the UK must be registered with the General Pharmaceutical Council, and you can search for any provider by name or registration number in seconds. If a website is not on that register, it is not a regulated UK pharmacy, full stop.

Beyond registration, look at how the service handles clinical assessment. A regulated pharmacy requires a prescriber (a real person with a professional registration) to review your consultation before any medicine is dispensed. If the process feels more like an online checkout than a clinical assessment, that is worth pausing on. You can read more about how semaglutide works and what a clinical assessment involves on the semaglutide overview page.

At nume, every consultation is read by a GPhC-registered Independent Prescriber, not software, not an automated filter. We do not run discount codes or promotional offers, and we are straightforward about why: cheapest is not the right measure for a prescription medicine. What matters is whether the medicine is genuine, whether the prescriber has assessed you properly, and whether there is clinical support if something changes. Anyone comparing providers may also find it useful to look at how semaglutide sales are structured across different services, since the variation in what is included can be significant. You can read more about how Wegovy is prescribed and dispensed through our service if you want the detail.

Can I get Wegovy on the NHS instead of paying privately?

Yes, in some circumstances, though access is phased and criteria are strict. NICE recommended semaglutide (Wegovy) for NHS use under Technology Appraisal 875, but only within specialist weight management services, for a maximum of two years, and for adults with a BMI of at least 35 alongside at least one weight-related health condition. Waiting lists through specialist services are commonly long.

NHS England is also rolling out tirzepatide (Mounjaro) in phases through primary care, with the first cohort (adults with a BMI of 40 or above plus four or more qualifying conditions) eligible from June 2025. The criteria are narrowing with each phase, but the point is that many people who would benefit clinically do not currently meet the NHS thresholds, or simply cannot wait.

Private treatment through a regulated online pharmacy is the practical alternative for people in that position. There are no referral requirements and no waiting lists, though clinical suitability is still assessed before anything is prescribed. If you want to understand your options side by side, the weight-loss treatment overview sets out what is licensed, what is available on the NHS, and what private routes look like. When you are ready to talk to a prescriber, starting a free consultation is the first step.